BAM vs CNS
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Nov 11, 2026
BAM
33.7
AI Score
VS
CNS Wins
CNS
43.0
AI Score
Investment Advisor Scores
CNS
43score
Recommendation
HOLD
AI Analyst Insights
AI insights temporarily unavailable
Detailed Metrics Comparison
| Metric | BAM | CNS | Winner |
|---|---|---|---|
| Revenue | 5.24B | 94.41M | BAM |
| Net Income | 4.76B | 29.96M | BAM |
| Net Margin | 90.8% | 31.7% | BAM |
| ROE | 40.3% | 9.9% | BAM |
| ROA | 17.4% | 6.7% | BAM |
| Total Assets | 27.41B | 450.12M | BAM |
| Cash | 657.00M | 193.73M | BAM |
Relative Price Performance (Last 90 Days)
BAM 1M: +16.2%
· 3M: -5.9%
CNS 1M: +5.6%
· 3M: -15.1%
Current Technical Phase
BAM
NeutralHold
Mixed signals - no dominant trend phase, RSI 63
CNS
DistributionTrim / tighten stop
Price near a flattening SMA50 (slope -5.6%) with fading momentum, RSI 50
Fundamentals Snapshot
| Metric | BAM | CNS |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 24.4 | 19.6 |
| Trailing P/E | 18.1 | 22.7 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.7% | 0.1% |
| Gross Margin | 0.8% | 0.5% |
| Operating Margin | 0.7% | 0.3% |
| EPS | 2.95 | 3.25 |
| Dividend Yield | 0.04% | 0.04% |
Frequently Asked Questions
Based on our detailed analysis, CNS is currently the stronger investment candidate based on our comprehensive scoring model.
We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.
Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.